Congresses
The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Michael J. Doane,1 Marco Boeri,2,3 Caroline Vass,4,5 Cooper Bussberg,6 Hemangi R. Panchmatia,1 Sabina Gasper,1 Leslie Citrome,7 Martha Sajatovic8
1Alkermes, Inc., Waltham, MA, USA; 2Health Preference Assessment, RTI Health Solutions, Belfast, Northern Ireland, UK; 3Queen’s University Belfast, Belfast, Northern Ireland, UK; 4University of Manchester, Manchester, England, UK; 5Health Preference Assessment, RTI Health Solutions, Manchester, England, UK; 6Health Preference Assessment, RTI Health Solutions, Research Triangle Park, NC, USA; 7New York Medical College, Valhalla, NY, USA; 8University Hospitals of Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA
